Development of Systemic siRNA-Based Cancer Therapeutics with a Confirmed RNAi-Mediated Mechanism of Action

被引:0
|
作者
Judge, Adam [1 ]
McClintock, Kevin [1 ]
Robbins, Marjorie [1 ]
Fronda, Anna [1 ]
Tavakoli, Iran [1 ]
Hu, Lina [1 ]
Yaworski, Ed [1 ]
Jeffs, Lloyd [1 ]
Ambegia, Ellen [1 ]
MacLachlan, Ian [1 ]
机构
[1] Tekmira Pharmaceut Corp, Burnaby, BC, Canada
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
422
引用
收藏
页码:S165 / S165
页数:1
相关论文
共 22 条
  • [1] Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
    Judge, Adam D.
    Robbins, Marjorie
    Tavakoli, Iran
    Levi, Jasna
    Hu, Lina
    Fronda, Anna
    Ambegia, Ellen
    McClintock, Kevin
    MacLachlan, Ian
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (03): : 661 - 673
  • [2] Advances in the development of siRNA-based therapeutics for cancer
    Shen, Yu
    [J]. IDRUGS, 2008, 11 (08) : 572 - 578
  • [3] Development of siRNA-based therapeutics
    Polisky, Barry
    [J]. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2004, 40 : 2A - 2A
  • [4] Preclinical and clinical development of siRNA-based therapeutics
    Ozcan, Gulnihal
    Ozpolat, Bulent
    Coleman, Robert L.
    Sood, Anil K.
    Lopez-Berestein, Gabriel
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2015, 87 : 108 - 119
  • [5] Clinical experiences with systemically administered siRNA-based therapeutics in cancer
    Zuckerman, Jonathan E.
    Davis, Mark E.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (12) : 843 - 856
  • [6] Clinical experiences with systemically administered siRNA-based therapeutics in cancer
    Jonathan E. Zuckerman
    Mark E. Davis
    [J]. Nature Reviews Drug Discovery, 2015, 14 : 843 - 856
  • [7] Development of RNAi technology for targeted therapy - A track of siRNA based agents to RNAi therapeutics
    Zhou, Yinjian
    Zhang, Chunling
    Liang, Wei
    [J]. JOURNAL OF CONTROLLED RELEASE, 2014, 193 : 270 - 281
  • [8] Superparamagnetic Nanoparticles and RNAi-Mediated Gene Silencing: Evolving Class of Cancer Diagnostics and Therapeutics
    Dey, Sanchareeka
    Maiti, Tapas K.
    [J]. JOURNAL OF NANOMATERIALS, 2012, 2012
  • [9] RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo
    Urban-Klein, B
    Werth, S
    Abuharbeid, S
    Czubayko, F
    Aigner, A
    [J]. GENE THERAPY, 2005, 12 (05) : 461 - 466
  • [10] SYSTEMIC DELIVERY OF siRNA-BASED THERAPEUTICS USING FUNCTIONALISED SINGLE-WALLED CARBON NANOTUBES
    Tan, Y.
    Cheong, S.
    Leong, C.
    [J]. CYTOTHERAPY, 2016, 18 (06) : S25 - S25